NMCIX
Price
$27.01
Change
+$0.36 (+1.35%)
Updated
Jul 3 closing price
Net Assets
726.9M
RRMGX
Price
$89.71
Change
+$0.38 (+0.43%)
Updated
Jul 3 closing price
Net Assets
28B
Interact to see
Advertisement

NMCIX vs RRMGX

Header iconNMCIX vs RRMGX Comparison
Open Charts NMCIX vs RRMGXBanner chart's image
Voya MidCap Opportunities I
Price$27.01
Change+$0.36 (+1.35%)
VolumeN/A
Net Assets726.9M
T. Rowe Price Mid-Cap Growth R
Price$89.71
Change+$0.38 (+0.43%)
VolumeN/A
Net Assets28B
NMCIX vs RRMGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NMCIX vs. RRMGX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMCIX is a Buy and RRMGX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 28B vs. NMCIX (727M). NMCIX (0.00) and RRMGX (0.00) have matching dividends . NMCIX was incepted earlier than RRMGX: NMCIX (27 years) vs RRMGX (23 years). RRMGX (1.29) is less costly to investors than NMCIX (0.94). NMCIX is a more actively managed with annual turnover of: 70.00 vs. RRMGX (22.60). RRMGX has a lower initial minimum investment than NMCIX: RRMGX (2500) vs NMCIX (250000). NMCIX annual gain was more profitable for investors over the last year : 6.34 vs. RRMGX (-2.95). NMCIX return over 5 years is better than : 6.00 vs. RRMGX (2.39).
NMCIXRRMGXNMCIX / RRMGX
Total Expense Ratio0.931.2972%
Annual Report Gross Expense Ratio0.941.2973%
Fund Existence27 years23 years-
Gain YTD6.6322.036326%
Front LoadN/AN/A-
Min. Initial Investment250000250010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets727M28B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year6.34-2.95-215%
Returns for 3 years45.9211.65394%
Returns for 5 years6.002.39252%
Returns for 10 years4.0415.3426%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DXC16.240.28
+1.75%
DXC Technology Company
EQ0.32N/A
+0.78%
Equillium
CELH46.560.19
+0.41%
Celsius Holdings
ECX2.16-0.04
-1.82%
ECARX Holdings
ACTU6.59-0.15
-2.23%
Actuate Therapeutics Inc